Treatment of Acute Myeloid Leukemia With Hematopoietic Stem Cell Transplantation

Cortney V. Jones; Edward A. Copelan


Future Oncol. 2009;5(4):559-568. 

In This Article

Post-remission Chemotherapy

The term 'consolidation therapy' is firmly entrenched, but present understanding of leukemia biology would suggest that merely 'strengthening' of a remission, with persistence of leukemic cells that will eventually cause relapse, is a misguided goal. Post-remission therapy is a more accurate term for treatment with curative intent. Post-remission therapy choices consist of chemotherapy, and autologous or allogeneic transplantation. In nonelderly patients, chemotherapy commonly consists of three to four courses of high-dose cytarabine, which is more effective in prevention of relapse than multiple courses of lower doses of cytarabine combined with anthracyclines.[25,26,27] The beneficial effect of high-dose cytarabine (compared with other forms of chemotherapy) occurs in patients within 'good' or 'intermediate' risk groups classified by cytogenetic analysis ( Table 1 ).


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.